PNC Financial Services Group
QNCX icon

PNC Financial Services Group’s Quince Therapeutics QNCX Stock Holding History

PNC Financial Services Group’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Hold
0
– -$50 – 4816
2023
Q1 		– Hold
0
– – – 4641
2022
Q4 		– Hold
0
– – – 4744
2022
Q3 		– Hold
0
– – – 4580
2022
Q2 		– Hold
0
– – – 4673
2022
Q1 		– Sell
-1
Closed -$1.36K – 4671
2021
Q4 		$2K Buy
+1
New +$6.1K ﹤0.01% 4183

Other funds holding QNCX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KAM
Knightsbridge Asset Management Newport Beach, California $743M AUM 28.33% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PNC Financial Services Group's QNCX Position: Q2 2023 in Review

PNC Financial Services Group held its Quince Therapeutics (QNCX) position steady in Q2 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4816.

PNC Financial Services Group first reported a position in QNCX in Q4 2021 and has held it in 1 quarter since. The position peaked at $2K in Q4 2021. 38 funds tracked by Wall St. Rank hold QNCX as of Q2 2023.

  • PNC Financial Services Group held 0 shares of Quince Therapeutics worth $0 as of Q2 2023.
  • PNC Financial Services Group left its Quince Therapeutics share count unchanged in Q2 2023.
  • Quince Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2023, its #4816 holding.
  • PNC Financial Services Group first reported a position in Quince Therapeutics in Q4 2021 and has held it in 1 quarter since.
  • PNC Financial Services Group's Quince Therapeutics position peaked at $2K in Q4 2021.
  • 38 funds tracked by Wall St. Rank held Quince Therapeutics as of Q2 2023.

Based on PNC Financial Services Group's 13F filing for Q2 2023, filed 11 Aug 2023.